ATLANTA, Feb. 16 /PRNewswire/ -- MedAssets Supply Chain Systems, one of the fastest growing group purchasing organizations (GPO) in the U.S., has signed a contract with Elekta, Inc. and IMPAC Medical Systems, Inc., an Elekta company, for radiation oncology treatment products and IMPAC’s oncology- specific healthcare IT solutions. MedAssets is the first GPO to sign a joint Elekta/IMPAC contract since the companies combined in 2005.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO)
The contract includes the revolutionary Elekta Synergy(R) treatment delivery series and the MOSAIQ product spectrum. In addition, MedAssets has a contract with Elekta for stereotactic neurosurgical products, including Leksell Gamma Knife(R).
“We continually seek ways to offer our customers the best contracts and opportunities available, and we can do that through our relationship with Elekta,” stated Jerry Allen, Director of Radiology and Cardiovascular Services, MedAssets Supply Chain Systems.
The MedAssets contract continues Elekta’s strong relationships within the GPO market space. A majority of the top 10 healthcare group purchasing organizations in the U.S. now have provider contracts with Elekta for radiation oncology, stereotactic radiosurgery and associated neuroscience products.
“Hospital systems face intense pressure to maintain a competitive edge, both in terms of obtaining patient referrals and in attracting and retaining top-notch clinical staff,” said Anthony De Carolis, President and CEO of Elekta, Inc. and head of the U.S. operations of the Elekta Group. “Elekta’s proven, leading-edge clinical solutions offer hospitals and clinics the opportunity to both provide a higher level of patient care and grow their business within the communities they serve.”
“The customers of MedAssets will be among the first in the United States to benefit from the close collaboration and joint development between Elekta and IMPAC,” said Jay Hoey, CEO of IMPAC. “IMPAC’s oncology-specific healthcare IT solutions fully integrate with Elekta’s radiation oncology treatment solutions to improve patient outcomes and expedite workflow, benefiting both the patient and the treatment center.”
About MedAssets
MedAssets, headquartered in Atlanta, Georgia, improves healthcare providers’ margin and cash flow through revenue cycle and supply chain initiatives and decision support technology and services. As a strategic business partner, MedAssets can replace multiple vendors and decrease supply costs by 3-10 % and increase net patient revenue by 1-3 %. MedAssets Net Revenue Systems provides best-of-breed revenue solutions including strategic pricing, pre-bill charge capturing, and ongoing chargemaster management tools, all of which have been Peer Reviewed by the Healthcare Financial Management Association. MedAssets Net Revenue Systems also offers denials management and a tool to link supply cost data with charge data. MedAssets Supply Chain Systems is one of the fastest growing group purchasing organization in the U.S. and builds customized solutions encompassing procurement of common medical supplies, pharmaceuticals, physician preference supplies, food and nutrition items, and capital equipment. The newly formed MedAssets Analytical Systems offers supply chain analytics and decision support tools while clinical and operational consulting services are provided through MedAssets’ subsidiary, Aspen Healthcare Metrics. Avega Health Systems, a subsidiary of MedAssets, ranked “Best in KLAS” in Business Decision Support - KLAS Enterprises, LLC 2005. For more information about MedAssets go to www.medassets.com or contact Gary Johnson, corporate senior vice president of Marketing and Marketing Services, 100 North Point Center East, Suite 200, Alpharetta, GA 30022.
About Elekta
Elekta is an international medical technology group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta’s solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Clinical solutions include Leksell Gamma Knife(R) for non-invasive treatment of brain disorders and Elekta Synergy(R) for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group became the world’s largest supplier of oncology software.
Elekta’s systems and solutions are used in over 3,000 hospitals around the world to treat cancer and to manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approximately 1,700 employees, Elekta’s corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb.
About IMPAC Medical Systems
IMPAC Medical Systems, Inc., a company in the Elekta Group, provides healthcare IT solutions that streamline clinical and business operations across the spectrum of cancer care. IMPAC’s open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as best-of-breed systems for anatomic pathology, clinical laboratory, and cancer registry.
With products that range from diagnosis and treatment through long-term follow-up, IMPAC provides a comprehensive oncology management solution that helps improve overall communication, process efficiency and quality patient care. For more information, visit www.impac.com.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGOPRN Photo Desk, photodesk@prnewswire.comElekta, Inc.
CONTACT: Michelle Lee, PR and Advertising Manager, +1-770-670-2447, ormichelle.lee@elekta.com, or Investors, United States, Lars Jonsteg, VPInvestor Relations North America, +46-708-78-37-35, orlars.jonsteg@elekta.com, or International, Peter Ejemyr, Group VP CorporateCommunications, +46-733-611-000, or peter.ejemyr@elekta.com, all of Elekta,Inc.